by Brandon Poulter
A Harvard Medical School affiliate is planning to retract six studies and correct 31 papers due to an ongoing investigation into several senior cancer researchers and administrators, according to The Wall Street Journal.
The investigation involves more than 50 papers, four of which are co-authored by Dana-Farber Cancer Institute CEO and President Dr. Laurie Glimcher, according to the WSJ. The institute has not determined whether research misconduct occurred, although several requests for retractions and corrections have been sent to journals.
Chief Operating Officer Dr. William Hahn, Director of the Clinical Investigator Research Program Dr. Irene Ghobrial and program director of the Jerome Lipper Multiple Myeloma Center Dr. Kenneth Anderson also have papers they co-authored being investigated, the newspaper reported.
Sholto David, a molecular biologist, wrote a January blog post describing signs of image manipulation in scholarly works by the Harvard researchers. The institute also became aware of an unknown number of other papers last year with possible issues, which it is reviewing.
“We knew about many of these papers and their allegations before the blog post,” said Dr. Barrett Rollins, the institute’s research integrity officer.
Three papers criticized by David reportedly did not require corrections or retractions.
Harvard President Claudine Gay resigned Jan. 2 following several plagiarism allegations and a congressional hearing on Dec. 5 where she refused to say if calling for the genocide of Jews violated the school’s code of conduct. Gay had approved a weakened plagiarism policy as dean of the Faculty of Arts and Sciences in 2019, and that policy was later used to defend her.
– – –
Brandon Poulter is a reporter at Daily Caller News Foundation.
Photo “Dana-Farber Cancer Institute” by Dana-Farber Cancer Institute.
